Delivery Order SPE2DB24D2003-SPE2DB25FXKF6
Award Date
7/2/25
Potential Completion Date
7/3/25
Potential Value
$21K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of the pharmaceutical product MOUNJARO 10 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,632.54 and is a firm fixed-price delivery order. The awardee is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and has a performance period through May 28, 2025. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of the pharmaceutical product Mounjaro (15 mg/0.5 ml pen) to the Defense Logistics Agency (DLA). The contract has a ceiling value of $15,365.78 and a completion date of May 7, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order, with a firm fixed price pricing type. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Mounjaro (2.5 mg/0.5 ml pen, 0.5 ml) with a ceiling value of $1,578. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 28, 2024. This appears to be a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $2,720.90 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 3, 2025 with a completion date of July 7, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a substantial...
This federal contract award is for the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen, 0.5 ml, with a ceiling value of $3,748.35 and a performance period ending on July 1, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This is a delivery order contract with a firm-fixed-price pricing type. The contract does not have a...
This federal contract award is for the delivery of the drug Mounjaro (7.5 mg/0.5 ml pen, 0.5 ml) to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $4,574.47, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and has an ultimate completion date of May 18, 2023. This contract does not have a set-aside designation, indicating it...
This federal contract award, valued at $1,317.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication Mounjaro 10 mg/0.5 ml pen. The contract is a firm fixed-price delivery order with an ultimate completion date of April 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $6,934.85 and is a Firm Fixed Price Delivery Order awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award is for the delivery of the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The $3,265.08 firm fixed price contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 2, 2025 with a completion date of July 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00...
The federal contract award is for the delivery of Mounjaro 10 mg/0.5 ml pen (0.5 ml) to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $2,630 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract does not have a set-aside designation, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...